Over 10 years experience of Traceability Solutions
By pharmatrax
Category: News
No Comments
Emcure Pharmaceuticals has had its share of run-ins with the FDA in the past over the sterility of one of its Indian manufacturing plants. Now,…
By pharmatrax
Category: News
No Comments
The FDA posted a public missive alongside a warning letter to a Chinese OTC drug manufacturer, highlighting the efforts it had been making to address…
By pharmatrax
Category: Technoloy
No Comments
By Kellie Rademacher, Pharm.D., Precision for Value Former FDA Commissioner Dr. Scott Gottlieb stressed the need for modernizing the clinical trials process in a speech…
By pharmatrax
Category: News
No Comments
Valisure warns FDA officials that the pharmacy found high levels of dimethylformamide in valsartan, a heart pill manufactured by Novartis. Valisure is an online pharmacy…
By pharmatrax
Category: News
No Comments
Medtronic is recalling older, discontinued versions of its MiniMed insulin pump over potential cybersecurity risks, saying they may be vulnerable to unwanted, remote settings changes.…
By pharmatrax
Category: News
No Comments
FDA inspectors continue to chew up Aurobindo Pharma, finding more failures that raise questions about the quality of drugs produced by the Indian drugmaker. Just…
By pharmatrax
Category: News
No Comments
Teva has expanded a recall of losartan potassium tablets after tests revealed a potential human carcinogen in the blood pressure drug. The Israeli pharma earlier…
By pharmatrax
Category: News
No Comments
Sanofi has received approval from the US FDA for 0.5ml Fluzone Quadrivalent vaccine to treat influenza in children aged between six and 35 months. Sanofi…
By pharmatrax
Category: News
No Comments
The FDA on Friday approved a one-time gene therapy that treats a rare genetic disease — for a record-breaking sticker price of $2.1 million. The approval of…
By pharmatrax
Category: Technoloy
No Comments
Despite the growth of the world’s population and the increasing demand for drugs, the pharmaceutical industry has traditionally not innovated at the same pace. According…